Studies with InBody regarding diabetes and endocrinology

 

DescriptionStudies using InBody in diabetic health and endocrinologyLast Updated2018
# of Studies34FieldDiabetes/Endocrinology

 

Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes
2018 / InBody 770 / Diabetes Care Center, Jinnouchi Hospital, Kumamoto, Japan
Seigo Sugiyama, Hideaki Jinnouchi, Noboru Kurinami, Kunio Hieshima, Akira Yoshida, Katsunori Jinnouchi, Hiroyuki Nishimura, Tomoko Suzuki, Fumio Miyamoto, Keizo Kajiwara, and Tomio Jinnouchi. Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes. J Atheroscler Thromb, 2018; 25: 467-476.

Changes in Body Compositions and Basal Metabolic Rates during Treatment of Graves’ Disease
2018 / InBody 720 / Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
Min Joo Kim, Sun Wook Cho, Sumin Choi, Dal Lae Ju, Do Joon Park, and Young Joo Park. Changes in Body Compositions and Basal Metabolic Rates during Treatment of Graves’ Disease. International Journal of Endocrinology Volume 2018, Article ID 9863050, 8 pages.

Effects of Ipragliflozin on Postprandial Glucose Metabolism and Gut Peptides in Type 2 Diabetes: A Pilot Study
2018 / InBody 720 / Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
Hiroaki Ueno, Hiroko Nakazato, Emi Ebihara, Kenji Noma, Takahisa Kawano, Kazuhiro Nagamine, Hideyuki Sakoda, Masamitsu Nakazato. Effects of Ipragliflozin on Postprandial Glucose Metabolism and Gut Peptides in Type 2 Diabetes: A Pilot Study. Diabetes Ther (2018) 9:403–411

Efficacy of ipragliflozin as monotherapy or as add-on therapy with other oral antidiabetic medications for treating type 2 diabetes in Japanese patients with inadequate glycemic control
2018 / InBody 3.0 / Department of Internal Medicine, Naka Kinen Clinic, Naka, Ibaraki, Japan
Takeshi Osonoi, Shinya Nakamoto, Miyoko Saito, Atsuko Tamasawa, Hidenori Ishida, Yusuke Osonoi. Efficacy of ipragliflozin as monotherapy or as add-on therapy with other oral antidiabetic medications for treating type 2 diabetes in Japanese patients with inadequate glycemic control: A subgroup analysis based on patient characteristics. J Diabetes Investig 2018; 9: 341–353

Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus
2018 / InBody 770 / Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Kurashiki, Japan
Shinji Kamei, Masahiro Iwamoto, Miyuki Kameyama, Masashi Shimoda, Tomoe Kinoshita, Atsushi Obata, Tomohiko Kimura, Hidenori Hirukawa, Fuminori Tatsumi, Kenji Kohara, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, and Hideaki Kaneto. Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus. Journal of Diabetes Research Volume 2018, Article ID 6470137, 6 pages

Glucose-independent segmental phase angles from multi-frequency bioimpedance analysis to discriminate diabetes mellitus
2018 / InBody S10 / KM Fundamental Research Division, Korea Institute of Oriental Medicine (KIOM), Daejeon, Korea
Min-Ho Jun, Soochan Kim, Boncho Ku, JungHee Cho, Kahye Kim, Ho-Ryong Yoo & Jaeuk U. Kim. Glucose-independent segmental phase angles from multi-frequency bioimpedance analysis to discriminate diabetes mellitus. Scientific Reports | (2018) 8:648

Changes in Body Composition According to Age and Sex among Young Non-Diabetic Korean Adults
2017 / InBody 3.0 / Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul
Seul-Ki Kim, Yu-Hyun Kwon, Jung Hwan Cho, Da Young Lee, Se Eun Park, Hyung-Geun Oh, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee. Changes in Body Composition According to Age and Sex among Young Non-Diabetic Korean Adults: The Kangbuk Samsung Health Study. Endocrinol Metab 2017;32:442-450.

Rapid Weight Loss vs. Slow Weight Loss: Which is More Effective on Body Composition and Metabolic Risk Factors?
2017 / InBody 230 / Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Damoon Ashtary-Larky, Matin Ghanavati, Nasrin Lamuchi-Deli, Seyedeh Arefeh Payami, Sara Alavi-Rad, Mehdi Boustaninejad, Reza Afrisham, Amir Abbasnezhad, and Meysam Alipour. Rapid Weight Loss vs. Slow Weight Loss: Which is More Effective on Body Composition and Metabolic Risk Factors?. Int J Endocrinol Metab. 2017 July; 15(3):e13249

Switching from low-dose thiazide diuretics to sodium-glucose cotransporter 2 inhibitor improves various metabolic parameters without affecting blood pressure in patients with type 2 diabetes and hypertension
2017 / InBody 770 / Division of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Kurashiki, Okayama, Japan
Tomohiko Kimura, Junpei Sanada, Masashi Shimoda, Hidenori Hirukawa, Yoshiro Fushimi, Momoyo Nishioka, Tomoe Kinoshita, Seizo Okauchi, Atsushi Obata, Kenji Kohara, Fuminori Tatsumi, Shinji Kamei, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto. Switching from low-dose thiazide diuretics to sodium–glucose cotransporter 2 inhibitor improves various metabolic parameters without affecting blood pressure in patients with type 2 diabetes and hypertension. J Diabetes Investig 2017.

Sodium-Glucose cotransporter 2 Inhibition with Dapagliflozin Ameliorates Extracellular Volume Expansion in Diabetic Kidney Disease Patients
2017 / InBody S10 / Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Tochigi, Japan
Takahiro Masuda, Ken Ohara, Takuya Murakami, Toshimi Imai, Saki Nakagawa, Mari Okada, Atsushi Miki, Akihiro Myoga, Akira Onishi, Chuji Sekiguchi, Yasuharu Miyazawa, Tetsu Akimoto,Osamu Saito, Shigeaki Muto, and Daisuke Nagata. Sodium-Glucose cotransporter 2 Inhibition with Dapagliflozin Ameliorates Extracellular Volume Expansion in Diabetic Kidney Disease Patients. POJ Diabetes Obes.1(1):1-8(2017)

Protein Intake, Especially Vegetable Protein Intake, Is Associated with Higher Skeletal Muscle Mass in Elderly Patients with Type 2 Diabetes
2017 / InBody 720 / Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan
Akane Miki, Yoshitaka Hashimoto, Shinobu Matsumoto, Emi Ushigome, Takuya Fukuda, Takafumi Sennmaru, Muhei Tanaka, Masahiro Yamazaki, and Michiaki Fukui. Protein Intake, Especially Vegetable Protein Intake, Is Associated with Higher Skeletal Muscle Mass in Elderly Patients with Type 2 Diabetes. Journal of Diabetes Research Volume 2017, Article ID 7985728, 7 pages

Relative muscle mass and the risk of incident type 2 diabetes: A cohort study
2017 / InBody 720 / Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
Sungwoo Hong, Yoosoo Chang, Hyun-Suk Jung, Kyung Eun Yun, Hocheol Shin, Seungho Ryu. Relative muscle mass and the risk of incident type 2 diabetes: A cohort study. PLOS ONE | https://doi.org/10.1371/journal.pone.0188650 | November 30, 2017

Effect of Antithyroid Therapies on Bone and Body Composition: A Prospective, Randomized, Clinical Study Comparing Antithyroid Drugs with Radioiodine Therapy
2017 / InBody 720 / Department of Endocrinology, Army Hospital(R&R), New Delhi, India
Shekhar Kansara, Narendra Kotwal, K. V. S. Hari Kumar, Yashpal Singh, Vimal Upreti, Amit Nachankar. Effect of Antithyroid Therapies on Bone and Body Composition: A Prospective, Randomized, Clinical Study Comparing Antithyroid Drugs with Radioiodine Therapy. Indian J Endocr Metab 2017;21:531-4.

Sodium-glucose cotransporter-2 inhibitor luseogliflozin added to glucagon-like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes
2017 / InBody S10 / Kansai Electric Power Hospital, Osaka, Japan
Yutaka Seino, Daisuke Yabe, Takashi Sasaki, Atsushi Fukatsu, Hisae Imazeki, Hidekazu Ochiai, Soichi Sakai. Sodium-glucose cotransporter-2 inhibitor luseogliflozin added to glucagon-like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52-week, open-label, single-arm study. J Diabetes Investig 2017 May

Advanced glycation end-products are a risk for muscle weakness in Japanese patients with type 1 diabetes
2017 / InBody 230 / Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan
Hiroyasu Mori, Akio Kuroda, Michiko Araki, Reiko Suzuki, Satoshi Taniguchi, Motoyuki Tamaki, Yuko Akehi, Munehide Matsuhisa. Advanced glycation end-products are a risk for muscle weakness in Japanese patients with type 1 diabetes. J Diabetes Investig 2017; 8: 377–382

Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes receiving conventional therapy: clinical implication of the importance of exercise habits during treatment with ipragliflozin
2017 / InBody 720 / Kato Clinic of Internal Medicine, Tokyo, Japan
Mitsutoshi Kato, Kumiko Sakai, Kyoko Saito, Kensuke Tsutsui, Shigeo Yamashita, Noriko Kato. Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes receiving conventional therapy: clinical implication of the importance of exercise habits during treatment with ipragliflozin. Diabetol Int. 2017.

Correlation of body muscle/fat ratio with insulin sensitivity using hyperinsulinemic-euglycemic clamp in treatment-native type 2 diabetes mellitus
2016 / InBody 770 / Diabetes Care Center, Jinnouchi Hospital, Kumamoto, Japan
Noboru Kurinami, Seigo Sugiyamaa, Akira Yoshida, Kunio Hieshima, Fumio Miyamoto, Keizo Kajiwara, Tomio Jinnouchi, Hideaki Jinnouchi. Correlation of body muscle/fat ratio with insulin sensitivity using hyperinsulinemic-euglycemic clamp in treatment-naı¨ve type 2 diabetes mellitus. diabetes research and clinical practice 120 (2016)65–72

Amelioration of fatty liver index in patients with type 2 diabetes on ipragliflozin: an association with glucose-lowering effects
2016 / InBody 720 / Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Takahiro Takase, Akinobu Nakamura, Hideaki Miyoshi, Chiho Yamamoto and Tatsuya Atsumi. Amelioration of fatty liver index in patients with type 2 diabetes on ipragliflozin: an association with glucose-lowering effects. Endocr J. 2016 Dec 13.

Ipragliflozin effectively reduced visceral fat in Japanese patients with type 2 diabetes under adequate diet therapy
2016 / InBody 720 / Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Chiho Yamamoto, Hideaki Miyoshi, Kota Ono, Hajime Sugawara, Reina Kameda, Mei Ichiyama, Kohei Yamamoto, Hiroshi Nomoto, Akinobu Nakamura and Tatsuya Atsumi. Ipragliflozin effectively reduced visceral fat in Japanese patients with type 2 diabetes under adequate diet therapy. Endocr J. 2016 Jun 30;63(6):589-96

The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes
2016 / InBody 720 / Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan
Yoshitaka Hashimoto, Takafumi Osaka, Takuya Fukuda, Muhei Tanaka, Masahiro Yamazaki and Michiaki Fukui. The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes. Endocr J. 2016 Jul 9.

Changes in Fasting Plasma Glucose, HbA1c and Triglycerides Are Related to Changes in Body Composition in Patients with Type 2 Diabetes
2016 / InBody 720 / Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Anca HANCU, Gabriela RADULIAN. Changes in Fasting Plasma Glucose, HbA1c and Triglycerides Are Related to Changes in Body Composition in Patients with Type 2 Diabetes. MAEDICA – a Journal of Clinical Medicine 2016; 11(5): 32-37

Effects of Short-Term Exenatide Treatment on Regional Fat Distribution, Glycated Hemoglobin Levels, and Aortic Pulse Wave Velocity of Obese Type 2 Diabetes Mellitus Patients
2016 / InBody 720 / Division of Endocrinology, Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea
Ju-Young Hong, Keun-Young Park, Byung-Joon Kim, Won-Min Hwang, Dong-Ho Kim, Dong-Mee Lim. Effects of Short-Term Exenatide Treatment on Regional Fat Distribution, Glycated Hemoglobin Levels, and Aortic Pulse Wave Velocity of Obese Type 2 Diabetes Mellitus Patients. Endocrinol Metab 2016;31:80-85

Appendicular Skeletal Muscle Mass and Insulin Resistance in an Elderly Korean Population
2015 / InBody 370 / Department of Public Health, Yonsei University Graduate School, Seoul, Korea
Seung Won Lee, Yoosik Youm, Won Joon Lee, Wungrak Choi, Sang Hui Chu, Yeong-Ran Park, Hyeon Chang Kim. Appendicular Skeletal Muscle Mass and Insulin Resistance in an Elderly Korean Population: The Korean Social Life, Health and Aging Project-Health Examination Cohort. Diabetes Metab J 2015;39:37-45.

イプラグリフロジン(SGLT2阻害薬)の臨床的効果とBIA法による体成分変化の検討
2014 / InBody 770 / Takagi Internal Medical Clinic, Kyoto, Japan
高木秀一、高木美幸、樹山敦子、中村直登. イプラグリフロジン(SGLT2阻害薬)の臨床的効果とBIA法による体成分変化の検討. Progress in Medicine Vol.34, No.12, 2014.12, 2229-2235.

Variation in Serum Creatinine Level Is Correlated to Risk of Type 2 Diabetes
2013 / InBody 720 / Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea
Jun Sung Moon, Ji Eun Lee, Ji Sung Yoon. Variation in Serum Creatinine Level Is Correlated to Risk of Type 2 Diabetes. Endocrinol Metab 2013;28:207-213

The Role of Skeletal Muscle in Development of Nonalcoholic Fatty Liver Disease
2013 / InBody 720 / Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea
Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee. The Role of Skeletal Muscle in Development of Nonalcoholic Fatty Liver Disease. Diabetes Metab J 2013;37:278-285

Subcutaneous fat of extremities independent of abdominal fat does not promote insulin resistance and cardiovascular risk in Japanese type 2 diabetic patients
2013 / InBody 720 / Division of Endocrinology and Metabolism, Kurume University School of Medicine, Kurume, Japan
Yuji Tajiri , Koji Yonemoto, Kentaro Yamada. Subcutaneous fat of extremities independent of abdominal fat does not promote insulin resistance and cardiovascular risk in Japanese type 2 diabetic patients. Diabetol Int 2013;4:45–51

 Seasonal variation in visceral fat and blood HbA1c in people with type 2 diabetes
2012 / InBody 720 / Division of Dietary Service, Mie University School Hospital, Tsu, Japan
Motoh Iwasa, Tomoe Nakatani, Yutaka Yano, Rumi Mifuji-Moroka, Nagisa Hara, Miho Akamatsu, Masumi Ishidome, Yoshiyuki Takei. Seasonal variation in visceral fat and blood HbA1c in people with type 2 diabetes. diabetes research and clinical practice 96 (2012) e53–e54

The Effect of Egg Consumption in Hyperlipidemic Subjects during Treatment with Lipid-Lowering Drugs
2012 / InBody 720 / Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Theerawut Klangjareonchai, Supanee Putadechakum, Piyamitr Sritara, Chulaporn Roongpisuthipong. The Effect of Egg Consumption in Hyperlipidemic Subjects during Treatment with Lipid-Lowering Drugs. Journal of Lipids 2012;Article ID 672720, 4 pages

Visceral fat volume predicts new-onset type 2 diabetes in patients with chronic hepatitis C
2011 / InBody 720 / Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, Tsu, Japan
Motoh Iwasa, Rumi Mifuji-Moroka, Nagisa Hara, Masumi Ishidome, Kazuko Iwata, Ryosuke Sugimoto, Hideaki Tanaka, Naoki Fujita, Yoshinao Kobayashi, Yoshiyuki Takei. Visceral fat volume predicts new-onset type 2 diabetes in patients with chronic hepatitis C. Diabetes Research and Clinical Practice 2011;94:468–470

Reduction of Skeletal Muscle, Especially in Lower Limbs in Japanese Type 2 Diabetic Patients with Insulin Resistance and Cardiovascular Risk Factors
2010 / InBody 720 / Endocrinology and Metabolism Division, Kurume University School of Medicine, Kurume, Japan
Yuji Tajiri, Tomoko Kato, Hitomi Nakayama, Kentaro Yamada. Reduction of Skeletal Muscle, Especially in Lower Limbs in Japanese Type 2 Diabetic Patients with Insulin Resistance and Cardiovascular Risk Factors. Metabolic Syndrome and Related Disorders 2010; 8:2

Derivation of a new equation for estimating creatinine clearance by using fat-free mass and serum creatinine concentration in Korean patients with type 2 diabetes mellitus
2009 / InBody 2.0 / Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul, Korea
Eunkyung Lee, Youngmin Cho, Jintaek Kim, Bokyung Koo, Hwayoung Cho, Yunhyi Ku, Kyongsoo Park, Hakchul Jang, Seongyeon Kim, Hongkyu Lee. Derivation of a new equation for estimating creatinine clearance by using fat-free mass and serum creatinine concentration in Korean patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 2009:83;44–49

Visceral Fatness and Insulin Sensitivity in Women With a Previous History of Gestational Diabetes Mellitus
2007 / InBody 3.0 / Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
SOO LIM, SUNG HEE CHOI, YOUNG JOO PARK, KYONG SOO PARK, HONG KYU LEE, HAK C. JANG, NAM H. CHO, BOYD E. METZGER. Visceral Fatness and Insulin Sensitivity in Women With a Previous History of Gestational Diabetes Mellitus. DIABETES CARE, VOLUME 30, NUMBER 2, FEBRUARY 2007